AstraZeneca buys rights to Alzheimer’s drug (AFP)
AFP - Anglo-Swedish drugs group AstraZeneca said snoop dogg
had agreed to pay up to 300 million dollars (252 million euros) to US peer Targacept for rights to help develop and market a drug to treat Alzheimer's disease and schizophrenia.